Lantheus Holdings (LNTH) Current Assets (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Current Assets of $942.3 million for Q1 2026, down 33.82% year-over-year from $1.4 billion in Q1 2025, and up 4.7% quarter-over-quarter from $900.0 million in Q4 2025.
Lantheus Holdings (LNTH) Current Assets (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Current Assets for 13 consecutive years, with $942.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 33.82% year-over-year to $942.3 million; the TTM figure through Mar 2026 stood at $942.3 million (down 33.82% YoY), while the FY2025 annual figure was $900.0 million, down 32.16% from the prior year.
- Current Assets climbed to $942.3 million in Q1 2026 per LNTH's latest filing, from $900.0 million in the prior quarter.
- Across five years, Current Assets topped out at $1.4 billion in Q1 2025 and bottomed at $324.7 million in Q1 2022.
- Historically, Current Assets has averaged $933.2 million across 5 years, with a median of $942.3 million in 2026.
- Annual changes were most pronounced in 2022 — Current Assets jumped 187.38% — and 2026, when it sank 33.82%.
- Lantheus Holdings' Current Assets stood at $677.6 million in 2022, then soared by 60.24% to $1.1 billion in 2023, then advanced by 22.18% to $1.3 billion in 2024, then tumbled by 32.16% to $900.0 million in 2025, then gained by 4.7% to $942.3 million in 2026.
- Business Quant data shows LNTH's Current Assets at $942.3 million in Q1 2026, $900.0 million in Q4 2025, and $925.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Bn |
| Mar 31, 2026 | 942.29 Mn |
| Dec 31, 2025 | 899.96 Mn |
| Sep 30, 2025 | 925.09 Mn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 1.42 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | 1.23 Bn |
| Mar 31, 2024 | 1.15 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 948.44 Mn |
| Jun 30, 2023 | 752.22 Mn |
| Mar 31, 2023 | 773.27 Mn |
| Dec 31, 2022 | 677.62 Mn |
| Sep 30, 2022 | 501.90 Mn |
| Jun 30, 2022 | 404.42 Mn |
| Mar 31, 2022 | 324.75 Mn |
| Dec 31, 2021 | 235.79 Mn |
| Sep 30, 2021 | 201.52 Mn |